These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 20060684)
1. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. De Hert M; Correll CU; Cohen D Schizophr Res; 2010 Mar; 117(1):68-74. PubMed ID: 20060684 [TBL] [Abstract][Full Text] [Related]
2. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203 [TBL] [Abstract][Full Text] [Related]
5. Risperidone and clozapine for treatment-resistant schizophrenia. Dunayevich E; Chatterjee A Am J Psychiatry; 1999 Jul; 156(7):1127; author reply 1127-8. PubMed ID: 10401486 [No Abstract] [Full Text] [Related]
6. Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up. Kiviniemi M; Suvisaari J; Koivumaa-Honkanen H; Häkkinen U; Isohanni M; Hakko H Schizophr Res; 2013 Oct; 150(1):274-80. PubMed ID: 23953217 [TBL] [Abstract][Full Text] [Related]
7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
8. Interpreting the results of the CATIE study. Pandiani JA; Banks SM Psychiatr Serv; 2006 Jan; 57(1):140-1. PubMed ID: 16399981 [No Abstract] [Full Text] [Related]
9. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162 [TBL] [Abstract][Full Text] [Related]
10. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics. Melkersson K; Lewitt M; Hall K Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia. Buckley PF; Goldstein JM; Emsley RA Schizophr Res; 2004 Feb; 66(2-3):143-50. PubMed ID: 15061246 [TBL] [Abstract][Full Text] [Related]
12. Impact of clozapine on completed suicide. Sernyak MJ; Desai R; Stolar M; Rosenheck R Am J Psychiatry; 2001 Jun; 158(6):931-7. PubMed ID: 11384902 [TBL] [Abstract][Full Text] [Related]
14. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914 [TBL] [Abstract][Full Text] [Related]
15. Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan. Chen WY; Chen PH; Pan CH; Su SS; Tsai SY; Chen CC; Kuo CJ Schizophr Res; 2024 Jun; 268():150-160. PubMed ID: 37479588 [TBL] [Abstract][Full Text] [Related]
16. Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine. Castro AP; Elkis H Braz J Psychiatry; 2007 Sep; 29(3):207-12. PubMed ID: 17891257 [TBL] [Abstract][Full Text] [Related]
17. Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years. Vermeulen JM; van Rooijen G; van de Kerkhof MPJ; Sutterland AL; Correll CU; de Haan L Schizophr Bull; 2019 Mar; 45(2):315-329. PubMed ID: 29697804 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study. Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013 [TBL] [Abstract][Full Text] [Related]
20. Risk of Mortality Among Patients Treated With Antipsychotic Medications: A Nationwide Population-Based Study in Taiwan. Wang LJ; Lee SY; Yuan SS; Yang KC; Yang CJ; Lee TL; Shyu YC J Clin Psychopharmacol; 2016 Feb; 36(1):9-17. PubMed ID: 26658260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]